The Ensign Group, Inc. is projected to rise to $200.64 by 2027, a +12% move from its current price of $178.83. ENSG is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/31/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 1 | $176.13 | $178.91 | $181.74 | +0.04% |
| Aug 2 | $175.06 | $178.99 | $183.00 | +0.09% |
| Aug 3 | $174.27 | $179.07 | $184.00 | +0.13% |
| Aug 4 | $173.62 | $179.15 | $184.86 | +0.18% |
| Aug 5 | $173.05 | $179.23 | $185.62 | +0.22% |
| Aug 6 | $172.55 | $179.31 | $186.33 | +0.27% |
| Aug 7 | $172.10 | $179.39 | $186.99 | +0.31% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $172.10 | $179.39 | $186.99 | +0.31% |
| Week 2 | $169.69 | $179.95 | $190.82 | +0.62% |
| Week 3 | $167.99 | $180.51 | $193.96 | +0.94% |
| Week 4 | $166.65 | $181.07 | $196.74 | +1.25% |
| Week 5 | $165.54 | $181.64 | $199.30 | +1.57% |
| Week 6 | $164.60 | $182.20 | $201.70 | +1.89% |
| Week 7 | $163.77 | $182.77 | $203.98 | +2.20% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
The Ensign Group, Inc. operates in the Healthcare sector, providing skilled nursing, senior living, and rehabilitative services. It operates through two segments: Skilled Services and Standard Bearer.
The Skilled Services segment provides short and long-term nursing care services for patients with chronic conditions, prolonged illness, and the elderly; specialty care, such as on-site dialysis, ventilator care, cardiac, and pulmonary management; and standard services, such as room and board, special nutritional programs, social services, recreational activities, entertainment, and other services. The Standard Bearer segment leases post-acute care properties to healthcare operators, and the company also operates senior living units and provides ancillary services including digital x-ray, ultrasound, electrocardiograms, sub-acute services, dialysis, respiratory, and long-term care pharmacy and patient transportation to people in their homes or at long-term care facilities, as well as mobile diagnostics. The company was incorporated in 1999 and is based in San Juan Capistrano, California.
It operates healthcare facilities in Alabama, Alaska, Arizona, Colorado, Idaho, Iowa, Kansas, Oregon, Nebraska, Nevada, South Carolina, Tennessee, Texas, Utah, Washington, and Wisconsin.
The Ensign Group, Inc. (ENSG) is a healthcare company with a market presence and a current price of $183.14 and a market capitalization of $10.67B. It is ranked 858 by market cap among listed equities.
The stock shows a bullish technical bias, with a 30-day price framework that sits near key levels and a defined range, suggesting potential upside over the forecast horizon. The current price sits near the 200-day moving average, and the 30-day range runs from $164.64 to $203.72, highlighting near-term volatility.
A major floor 20.4% below — a decisive break under it would weaken the trend.
The nearest floor, 14.1% below — buyers have tended to step in here.
Price is pressing into resistance (2.4% away) — a breakout level to watch.
A major ceiling 14.5% above — clearing it would confirm fresh momentum.
Key ENSG support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ENSG market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $178.98 | Sell | $178.44 | Buy |
| MA 10 | $174.57 | Buy | $175.69 | Buy |
| MA 20 | $171.72 | Buy | $172.24 | Buy |
| MA 50 | $166.32 | Buy | $171.26 | Buy |
| MA 100 | $180.26 | Sell | $175.35 | Buy |
| MA 200 | $182.81 | Sell | $175.64 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 61.17 | Neutral |
| Stoch RSI (14) | 58.49 | Neutral |
| CCI (20) | 125.39 | Buy |
| Williams %R (14) | -26.26 | Info |
| MACD (12,26,9) | 1.23 | Buy |
| ROC (12) | 7.26 | Buy |
| Bollinger %B (20,2) | 0.87 | Neutral |
| Stochastic %K (14) | 73.74 | Neutral |
| TRIX (15) | 0.23 | Buy |
| Awesome (5,34) | 13.10 | Buy |
| Ultimate (7,14,28) | 66.46 | Neutral |
| Momentum (10) | 5.94 | Buy |
| Aroon Osc (25) | 80.00 | Buy |
| Hull MA (9) | 183.91 | Sell |
| ADX (14) | 18.63 | Neutral |
| ATR (14) | 2.68 | Info |
Technical snapshot for the next 30 days shows bullish tilt with RSI at 70, indicating strong momentum. The simple moving average on a 50-day basis is $166.19, while the 200-day sits at $182.76. Support is identified at $150.71 and resistance at $183.14, framing the near-term trading zone.
The 30-day range spans from $164.64 to $203.72, and the annualized volatility stands at 30%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $147.13 | $178.83 | $230.00 | 0% | Neutral | |
| $164.51 | $200.64 | $255.71 | +12% | Neutral | |
| $179.05 | $222.53 | $291.39 | +24% | Bullish | |
| $190.44 | $240.37 | $321.53 | +34% | Bullish | |
| $217.36 | $278.07 | $378.71 | +55% | Bullish | |
| $253.70 | $328.55 | $454.58 | +84% | Bullish | |
| $271.83 | $356.02 | $499.63 | +99% | Bullish | |
| $296.99 | $393.09 | $558.82 | +120% | Bullish | |
| $299.07 | $399.78 | $575.15 | +124% | Bullish | |
| $299.58 | $404.27 | $588.10 | +126% | Bullish | |
| $457.31 | $643.70 | $981.45 | +260% | Bullish | |
| $812.83 | $1,227.15 | $2,005.87 | +586% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $147.13 | $178.83 | $208.19 | +0.00% |
| August 2026 | $154.47 | $180.11 | $214.03 | +0.72% |
| September 2026 | $158.81 | $186.24 | $223.39 | +3.40% |
| October 2026 | $160.54 | $189.14 | $228.55 | +1.56% |
| November 2026 | $157.88 | $186.70 | $226.96 | -1.29% |
| December 2026 | $158.58 | $188.17 | $230.00 | +0.79% |
Click any year to see its month-by-month ENSG forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, ENSG could reach as high as $230.00, with a base case around $178.83 and support toward $147.13 — roughly 0% from $178.83. Price action looks broadly range-bound.
Expect ENSG to range from $164.51 to $255.71 through 2027. The $200.64 average target implies a +12% move from current prices. That is up +12% on the projected 2026 average. A consolidation phase looks the most probable path here.
The ENSG price prediction for 2028 points to an average of $222.53 (low $179.05, high $291.39) — a potential gain of +24% on today's $178.83. Momentum favours further upside here.
In 2029, ENSG is projected to trade between $190.44 and $321.53, averaging $240.37 — a potential gain of +34% from today's $178.83. That is up +8% on the projected 2028 average. Buyers look set to stay in control over this stretch.
The Ensign Group, Inc.'s 2030 outlook centres on $278.07, within a $217.36 to $378.71 range. That is up +16% on the projected 2029 average. That marks a +55% change versus current levels. Momentum favours further upside here.
By 2031, ENSG could reach as high as $454.58, with a base case around $328.55 and support toward $253.70 — roughly +84% from $178.83. Buyers look set to stay in control over this stretch.
Expect ENSG to range from $271.83 to $499.63 through 2032. The $356.02 average target implies a +99% move from current prices. That is up +8% on the projected 2031 average. Momentum favours further upside here.
The ENSG price prediction for 2033 points to an average of $393.09 (low $296.99, high $558.82) — a potential gain of +120% on today's $178.83. Buyers look set to stay in control over this stretch.
In 2034, ENSG is projected to trade between $299.07 and $575.15, averaging $399.78 — a potential gain of +124% from today's $178.83. That is up +2% on the projected 2033 average. Momentum favours further upside here.
The Ensign Group, Inc.'s 2035 outlook centres on $404.27, within a $299.58 to $588.10 range. That is up +1% on the projected 2034 average. That marks a +126% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, ENSG could reach as high as $981.45, with a base case around $643.70 and support toward $457.31 — roughly +260% from $178.83. Momentum favours further upside here.
Expect ENSG to range from $812.83 to $2,005.87 through 2050. The $1,227.15 average target implies a +586% move from current prices. That is up +91% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in ENSG today (≈ 5.591903 ENSG) could be worth
$6,862.11
+$5,862.11 (+586%) by 2050 · US Dollar
Based on the average projected ENSG price of $1,227.15 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ENSGwould be worth at today's price.
$1,000 invested in ENSG on Jul 30, 2025 (≈ 6.64982 ENSG) would be worth
$1,189.19
+$189.19 (+18.9%) today · 1.19× · US Dollar
Based on a ENSG entry price of $150.38 vs. today's $178.83.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $167.52 | $1,067.51 | +6.8% |
| 1 month ago | $160.3 | $1,115.6 | +11.6% |
| 3 months ago | $183.72 | $973.38 | -2.7% |
| 6 months ago | $171.66 | $1,041.77 | +4.2% |
| 1 year ago | $150.38 | $1,189.19 | +18.9% |
| All time (5.0y) ago | $84.38 | $2,119.34 | +111.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ENSG forecast.
Our base-case forecast reaches $360.00 around 2033.
Implied market cap at $360.00: $20.98B
The multi-year forecast points to sustained upside, with a path of rising averages over time. The 2026 average price is $183.14, with a 2026 min of $147.13, a max of $236.27, and an ROI of 0%. In 2027, the average climbs to $206.33 (min $169.15, max $263.00) with an ROI of 12.7%.
By 2028, the average is $229.13 (min $184.34, max $300.07) and ROI 25.1%. The 2029 projection shows an average of $248.89 (min $197.17, max $332.96) and ROI 35.9%. In 2030, the average reaches $288.07 (min $225.16, max $392.36) with ROI 57.3% and bullish sentiment.
Long-range figures rise further, with 2031 at $340.64 (min $263.02, max $471.34) ROI 86%; 2032 at $370.41 (min $282.80, max $519.85) ROI 102.3%; 2033 at $408.22 (min $308.41, max $580.37) ROI 122.9%; 2034 at $415.42 (min $310.75, max $597.69) ROI 126.8%; 2035 at $421.99 (min $312.70, max $613.92) ROI 130.4%. The trajectory accelerates toward the 2040s and beyond, with 2040 averaging $672.95 (min $478.07, max $1,026.09) and ROI 267.4%, and 2050 averaging $1,292.63 (min $856.18, max $2,112.97) with ROI 605.8%, while sentiment remains BULLISH."
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $288.07 with a min of $225.16 and a max of $392.36, and an ROI of 57.3%. The sentiment is BULLISH for 2030.
Forecasts indicate a bullish outlook from 2028 onward, with 2028 average $229.13 and 2029 average $248.89, rising to 2030 average $288.07 (ROI 57.3%), 2040 average $672.95 (ROI 267.4%), and 2050 average $1,292.63 (ROI 605.8%). Earlier years show neutral to neutral-bullish signals, and these figures are estimates, not guarantees.
Yes. The 2033 forecast shows an average price of $408.22, which surpasses $400, with 2032 at $370.41 and 2034 at $415.42.
Current price is $183.14 and market cap is $10.67B. The stock is ranked 858 in market capitalization.
The 30-day range runs from a low of $164.64 to a high of $203.72.
The Ensign Group, Inc. Community Discussion
0Share your The Ensign Group, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.